Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
After founding the "Google for LLMs," You.com, Richard Socher's next company, Recursive AI, could automate AI research itself ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today ...
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the 11 most popular AI penny stocks to buy now. On February 25, Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) reported Q4 revenue of $35.5 million ...
For most companies, the honest answer is: nobody knows.
LGBTQ Nation on MSN
RFK tried to ban trans care for minors. A federal judge just stopped him.
The judge said he didn't follow the correct procedure for what is effectively a move to deny patients care.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果